Compliance statement
1 This statement has been prepared under accounting policies which comply with
accounting standards as defined in the Corporations Act or other standards acceptable
to ASX (see note 4).
2 This statement does /does not* (delete one) give a true and fair view of the matters
disclosed.
Sign here: Date: 15 April 2009
(Company secretary)
Print name: John Ribbons
Notes
1 The quarterly report provides a basis for informing the market how the entity’s
activities have been financed for the past quarter and the effect on its cash position.
An entity wanting to disclose additional information is encouraged to do so, in a note
or notes attached to this report.
2 The “Nature of interest” (items 6.1 and 6.2) includes options in respect of interests in
mining tenements acquired, exercised or lapsed during the reporting period. If the
entity is involved in a joint venture agreement and there are conditions precedent
which will change its percentage interest in a mining tenement, it should disclose the
change of percentage interest and conditions precedent in the list required for items
6.1 and 6.2.
3 Issued and quoted securities The issue price and amount paid up is not required in
items 7.1 and 7.3 for fully paid securities.
4 The definitions in, and provisions of, AASB 1022: Accounting for Extractive
Industries and AASB 1026: Statement of Cash Flows apply to this report.
5 Accounting Standards ASX will accept, for example, the use of International
Accounting Standards for foreign entities. If the standards used do not address a topic,
the Australian standard on that topic (if any) must be complied with.
== ==
- Forums
- ASX - By Stock
- AEV
- Ann: Appendix 5B
Ann: Appendix 5B , page-3
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $27.04M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $17.4K | 1.720M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 5987558 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 2047093 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 5987558 | 0.010 |
6 | 2526000 | 0.009 |
5 | 1504999 | 0.008 |
3 | 1400000 | 0.007 |
5 | 10755000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 2047093 | 7 |
0.013 | 5200066 | 8 |
0.014 | 599999 | 1 |
0.015 | 2790146 | 6 |
0.016 | 7619577 | 8 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online